Whittier Trust Co. of Nevada Inc. Decreases Holdings in Haleon plc (NYSE:HLN)

Whittier Trust Co. of Nevada Inc. decreased its position in shares of Haleon plc (NYSE:HLN) by 24.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 6,978 shares of the company’s stock after selling 2,214 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Haleon were worth $67,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Procyon Advisors LLC boosted its stake in shares of Haleon by 41.3% during the 4th quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after acquiring an additional 67,329 shares in the last quarter. HighTower Advisors LLC lifted its stake in Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after buying an additional 74,970 shares in the last quarter. Jane Street Group LLC lifted its stake in Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after buying an additional 250,169 shares in the last quarter. Townsquare Capital LLC lifted its stake in Haleon by 29.8% in the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after buying an additional 109,217 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Haleon by 25.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after buying an additional 1,026,939 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on HLN shares. Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Six investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $10.95.

Haleon Trading Down 1.0 %

Shares of HLN opened at $10.29 on Monday. The stock has a fifty day moving average of $9.84 and a two-hundred day moving average of $9.88. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a market capitalization of $46.56 billion, a PE ratio of 30.25, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. Haleon plc has a fifty-two week low of $7.99 and a fifty-two week high of $10.80.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. As a group, analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The company also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. This is an increase from Haleon’s previous — dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon’s dividend payout ratio is presently 58.97%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.